Literature DB >> 31519812

Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells.

Amber Papillion1, Michael D Powell2,3, Danielle A Chisolm4, Holly Bachus1, Michael J Fuller1, Amy S Weinmann4, Alejandro Villarino5, John J O'Shea5, Beatriz León4, Kenneth J Oestreich2,6,7, André Ballesteros-Tato8.   

Abstract

Sustained T cell receptor (TCR) stimulation is required for maintaining germinal center T follicular helper (GC-TFH) cells. Paradoxically, TCR activation induces interleukin-2 receptor (IL-2R) expression and IL-2 production, thereby initiating a feedback loop of IL-2 signaling that normally inhibits TFH cells. It is unclear how GC-TFH cells can receive prolonged TCR signaling without succumbing to the detrimental effects of IL-2. Using an influenza infection model, we show here that GC-TFH cells secreted large amounts of IL-2 but responded poorly to it. To maintain their IL-2 hyporesponsiveness, GC-TFH cells required intrinsic IL-6 signaling. Mechanistically, we found that IL-6 inhibited up-regulation of IL-2Rβ (CD122) by preventing association of STAT5 with the Il2rb locus, thus allowing GC-TFH cells to receive sustained TCR signaling and produce IL-2 without initiating a TCR/IL-2 inhibitory feedback loop. Collectively, our results identify a regulatory mechanism that controls the generation of GC-TFH cells.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31519812      PMCID: PMC6820141          DOI: 10.1126/sciimmunol.aaw7636

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  42 in total

1.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

Review 2.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

3.  CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model.

Authors:  Pushpa Pandiyan; Heather R Conti; Lixin Zheng; Alanna C Peterson; Douglas R Mathern; Nydiaris Hernández-Santos; Mira Edgerton; Sarah L Gaffen; Michael J Lenardo
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

Review 4.  T follicular regulatory (Tfr) cells: Dissecting the complexity of Tfr-cell compartments.

Authors:  Válter R Fonseca; Filipa Ribeiro; Luis Graca
Journal:  Immunol Rev       Date:  2019-03       Impact factor: 12.988

5.  IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.

Authors:  Byron B Au-Yeung; Geoffrey Alexander Smith; James L Mueller; Cheryl S Heyn; Rebecca Garrett Jaszczak; Arthur Weiss; Julie Zikherman
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

Review 6.  The biology of interleukin-2.

Authors:  Thomas R Malek
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

7.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.

Authors:  Roza I Nurieva; Yeonseok Chung; Daehee Hwang; Xuexian O Yang; Hong Soon Kang; Li Ma; Yi-hong Wang; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong
Journal:  Immunity       Date:  2008-07-03       Impact factor: 31.745

8.  ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide.

Authors:  Jason D Buenrostro; Beijing Wu; Howard Y Chang; William J Greenleaf
Journal:  Curr Protoc Mol Biol       Date:  2015-01-05

9.  FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability.

Authors:  Beatriz León; John E Bradley; Frances E Lund; Troy D Randall; André Ballesteros-Tato
Journal:  Nat Commun       Date:  2014-03-17       Impact factor: 14.919

10.  Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival.

Authors:  Gislâine A Martins; Luisa Cimmino; Jerry Liao; Erna Magnusdottir; Kathryn Calame
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

View more
  28 in total

Review 1.  Bcl6-Mediated Transcriptional Regulation of Follicular Helper T cells (TFH).

Authors:  Jinyong Choi; Shane Crotty
Journal:  Trends Immunol       Date:  2021-03-01       Impact factor: 16.687

2.  Intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling and promotes fate decisions, stemness, and protection.

Authors:  Shannon M Kahan; Rakesh K Bakshi; Jennifer T Ingram; R Curtis Hendrickson; Elliot J Lefkowitz; David K Crossman; Laurie E Harrington; Casey T Weaver; Allan J Zajac
Journal:  Sci Immunol       Date:  2022-02-11

3.  Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses.

Authors:  Young Min Son; In Su Cheon; Yue Wu; Chaofan Li; Zheng Wang; Xiaochen Gao; Yao Chen; Yoshimasa Takahashi; Yang-Xin Fu; Alexander L Dent; Mark H Kaplan; Justin J Taylor; Weiguo Cui; Jie Sun
Journal:  Sci Immunol       Date:  2021-01-08

Review 4.  Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity.

Authors:  Rebecca A Elsner; Mark J Shlomchik
Journal:  Immunity       Date:  2020-12-15       Impact factor: 31.745

Review 5.  The Potential of Harnessing IL-2-Mediated Immunosuppression to Prevent Pathogenic B Cell Responses.

Authors:  Amber Papillion; André Ballesteros-Tato
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

6.  Small Molecule Inhibitors of Nuclear Export and the Amelioration of Lupus by Modulation of Plasma Cell Generation and Survival.

Authors:  Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Teresa Owen; Jennifer Barnard; Enrique Becerril-Villanueva; Trinayan Kashyap; Christian Argueta; Armando Gamboa-Dominguez; Sharon Tamir; Yosef Landesman; Bruce I Goldman; Christopher T Ritchlin; Jennifer H Anolik
Journal:  Arthritis Rheumatol       Date:  2022-06-28       Impact factor: 15.483

7.  Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways.

Authors:  Ramin Sedaghat Herati; Luisa Victoria Silva; Laura A Vella; Alexander Muselman; Cecile Alanio; Bertram Bengsch; Raj K Kurupati; Senthil Kannan; Sasikanth Manne; Andrew V Kossenkov; David H Canaday; Susan A Doyle; Hildegund C J Ertl; Kenneth E Schmader; E John Wherry
Journal:  Cell Rep Med       Date:  2021-05-07

8.  Sustained low-dose interleukin-2 therapy alleviates pathogenic humoral immunity via elevating the Tfr/Tfh ratio in lupus.

Authors:  Kaili Liang; Jing He; Yunbo Wei; Qunxiong Zeng; Dongcheng Gong; Jiahuan Qin; Huihua Ding; Zhian Chen; Ping Zhou; Peng Niu; Qian Chen; Chenguang Ding; Liangjing Lu; Xiao-Xiang Chen; Zhanguo Li; Nan Shen; Di Yu; Jun Deng
Journal:  Clin Transl Immunology       Date:  2021-06-01

9.  Germinal Center T follicular helper (GC-Tfh) cell impairment in chronic HIV infection involves c-Maf signaling.

Authors:  Marita Chakhtoura; Mike Fang; Rafael Cubas; Margaret H O'Connor; Carmen N Nichols; Brian Richardson; Aarthi Talla; Susan Moir; Mark J Cameron; Virginie Tardif; Elias K Haddad
Journal:  PLoS Pathog       Date:  2021-07-19       Impact factor: 6.823

10.  CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties.

Authors:  Kristen M Valentine; Genevieve N Mullins; Oscar A Davalos; Lek Wei Seow; Katrina K Hoyer
Journal:  J Autoimmun       Date:  2021-07-16       Impact factor: 14.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.